Myriad Genetics
MYGN
#3882
Rank
C$3.48 B
Marketcap
$38.37
Share price
-0.63%
Change (1 day)
64.90%
Change (1 year)

Revenue for Myriad Genetics (MYGN)

Revenue in 2024 (TTM): C$1.08 B

According to Myriad Genetics's latest financial reports the company's current revenue (TTM) is C$1.08 B. In 2023 the company made a revenue of C$0.99 B an increase over the revenue in the year 2022 that were of C$0.92 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Myriad Genetics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) C$1.08 B8.61%
2023 C$0.99 B8.52%
2022 C$0.92 B5.33%
2021 C$0.87 B
2019 C$1.05 B-3.03%
2018 C$1.08 B13.19%
2017 C$0.96 B-4.8%
2016 C$1.00 B-2.68%
2015 C$1.03 B23.33%
2014 C$0.84 B7.21%
2013 C$0.78 B44.29%
2012 C$0.54 B20.6%
2011 C$0.45 B19.41%
2010 C$0.37 B3.71%
2009 C$0.36 B-22.89%
2008 C$0.47 B151.41%
2007 C$0.18 B21.67%
2006 C$0.15 B34.53%
2005 C$0.11 B61.25%
2004 C$71.11 M-8.99%
2003 C$78.14 M-17.13%
2002 C$94.29 M20.66%
2001 C$78.14 M25.25%
2000 C$62.39 M48.34%
1999 C$42.06 M16.41%
1998 C$36.13 M19.28%
1997 C$30.29 M148.48%
1996 C$12.19 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
C$3.47 B 219.45%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.54 B 225.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$4.67 M-100.43%๐Ÿ‡บ๐Ÿ‡ธ USA
C$3.51 B 222.66%๐Ÿ‡บ๐Ÿ‡ธ USA
C$55.23 B 4,976.66%๐Ÿ‡บ๐Ÿ‡ธ USA